Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

The Fos family of transcription factors and their role in tumourigenesis.

Milde-Langosch K.

Eur J Cancer. 2005 Nov;41(16):2449-61. Epub 2005 Sep 30. Review.

PMID:
16199154
[PubMed - indexed for MEDLINE]
2.

Transcription factor AP-1, and the role of Fra-2.

Foletta VC.

Immunol Cell Biol. 1996 Apr;74(2):121-33. Review.

PMID:
8723999
[PubMed - indexed for MEDLINE]
Free Article
3.

Fos family members: regulation, structure and role in oncogenic transformation.

Tulchinsky E.

Histol Histopathol. 2000 Jul;15(3):921-8. Review.

PMID:
10963134
[PubMed - indexed for MEDLINE]
4.

Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters.

Verde P, Casalino L, Talotta F, Yaniv M, Weitzman JB.

Cell Cycle. 2007 Nov 1;6(21):2633-9. Epub 2007 Aug 8. Review.

PMID:
17957143
[PubMed - indexed for MEDLINE]
Free Article
5.

Fra-1 a target for cancer prevention or intervention.

Young MR, Colburn NH.

Gene. 2006 Sep 1;379:1-11. Epub 2006 May 6. Review.

PMID:
16784822
[PubMed - indexed for MEDLINE]
6.

Invasion is a genetic program regulated by transcription factors.

Ozanne BW, Spence HJ, McGarry LC, Hennigan RF.

Curr Opin Genet Dev. 2006 Feb;16(1):65-70. Epub 2005 Dec 27. Review.

PMID:
16377173
[PubMed - indexed for MEDLINE]
7.

Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?

Basbous J, Jariel-Encontre I, Gomard T, Bossis G, Piechaczyk M.

Biochimie. 2008 Feb;90(2):296-305. Epub 2007 Jul 31. Review.

PMID:
17825471
[PubMed - indexed for MEDLINE]
8.

Translational regulation mechanisms of AP-1 proteins.

Vesely PW, Staber PB, Hoefler G, Kenner L.

Mutat Res. 2009 Jul-Aug;682(1):7-12. doi: 10.1016/j.mrrev.2009.01.001. Epub 2009 Jan 9. Review.

PMID:
19167516
[PubMed - indexed for MEDLINE]
9.

AP-1 and colorectal cancer.

Ashida R, Tominaga K, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Mitsuyama S, Iwao H, Arakawa T.

Inflammopharmacology. 2005;13(1-3):113-25. Review.

PMID:
16259733
[PubMed - indexed for MEDLINE]
10.

Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.

Zenz R, Wagner EF.

Int J Biochem Cell Biol. 2006;38(7):1043-9. Epub 2005 Dec 20. Review.

PMID:
16423552
[PubMed - indexed for MEDLINE]
11.

Breast cancer markers.

Giancotti V.

Cancer Lett. 2006 Nov 18;243(2):145-59. Epub 2006 Mar 10. Review.

PMID:
16530325
[PubMed - indexed for MEDLINE]
12.

The transcription factor ETS-1: its role in tumour development and strategies for its inhibition.

Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S, Wernert N.

Mini Rev Med Chem. 2008 Oct;8(11):1095-105. Review.

PMID:
18855726
[PubMed - indexed for MEDLINE]
13.

Immediate early response genes and cell transformation.

Healy S, Khan P, Davie JR.

Pharmacol Ther. 2013 Jan;137(1):64-77. doi: 10.1016/j.pharmthera.2012.09.001. Epub 2012 Sep 13. Review.

PMID:
22983151
[PubMed - indexed for MEDLINE]
14.

FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer.

Dhillon AS, Tulchinsky E.

Oncogene. 2014 Nov 10. doi: 10.1038/onc.2014.374. [Epub ahead of print] Review.

PMID:
25381818
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk